ASHG: Nabsys Links Cytogenetics and Genomics to Map Hematologic Cancers

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 27 Oct, 11:13 UTC

Blood cancers carry complex genomic rearrangements that no single assay fully captures. At ASHG 2026 in Montréal, Nabsys presented early data comparing its Electronic Genome Mapping technology with established cytogenetic methods and previewed new analysis software for hematologic malignancies. The…